FREE WEBINAR: In this practical session, Professor Jeremy Krebs will review key considerations for initiating and managing injectable therapies, including contraindications, dose titration, maintenance dosing, and intolerance management.
Jeremy will cover prevention and management of common gastrointestinal side effects and when treatment should be paused or stopped. He will also explore nutritional counselling, including protein adequacy, micronutrient considerations and preservation of muscle mass, alongside monitoring, defining treatment success or failure, and practical guidance on switching between semaglutide and tirzepatide.
Contraception counselling will also be discussed, including oral contraceptive absorption considerations, fertility implications.
As always, we will answer as many questions as possible.
Presenter
Jeremy Krebs
Professor Krebs is an Endocrinologist with a particular interest in obesity and diabetes. He trained in Endocrinology at Wellington Hospital in New Zealand and then did his doctorate with the Medical Research Council - Human Nutrition Research unit in Cambridge England. His thesis was on the impact of dietary factors on obesity and insulin resistance. Prof Krebs returned to New Zealand in 2002 to take up a consultant Endocrinology post at Wellington Hospital, where he was Clinical Leader of Endocrinology and Diabetes from 2007 to 2017. He is a past President of NZSSD. He is a Professor of Medicine with the University of Otago, and previously the Director of the Clinical Research Diploma at Victoria University.
As well as clinical and teaching activities, Prof Krebs leads a research group across the DHB and the University in the area of obesity and diabetes, with a focus on nutritional aspects, and diabetes service delivery. He has a wide range of collaborations across disciplines and institutions. These include working with basic scientists in genetics and immunology and with academic nutritionists.
Supported by an unrestricted educational grant from:
